Awareness Detection and Communication in Disorders of Consciousness
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- University of Ulster
- Principal Investigator
- Damien Coyle, PhDUniversity of Ulster
- Intervention
- Motor imagery based EEG-BCI(other)
- Enrollment
- 30 enrolled
- Eligibility
- 10-80 years · All sexes
- Timeline
- 2022 – 2026
Study locations (18)
- National Rehabilitation Hospital of Ireland, Dublin, Ireland
- Castel Froma Neuro Care, Warwick, Warwickshire, United Kingdom
- Northern Health and Social Care Trust, Antrim, United Kingdom
- Barnsley Hospital NHS Foundation Trust, Barnsley, United Kingdom
- Belfast Health and Social Care Trust, Belfast, United Kingdom
- Frenchay Brain Injury Rehabilitation Centre, Bristol, United Kingdom
- NHS Lothian, Edinburgh, United Kingdom
- Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom
- The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
- The Huntercombe Group, London, United Kingdom
- Royal Hospital for Neuro-Disability, London, United Kingdom
- Imperial College Healthcare NHS Trust, London, United Kingdom
- Western Health and Social Care Trust, Londonderry, United Kingdom
- Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- Southern Health and Social Care Trust, Portadown, United Kingdom
- +3 more locations on ClinicalTrials.gov
Collaborators
National Rehabilitation Hospital, Dublin, Ireland (NRH) · Belfast Health and Social Care Trust · Western Health and Social Care Trust · Southern Health and Social Care Trust · Northern Health and Social Care Trust · Barnsley Hospital NHS Foundation Trust · NHS Lothian · Walton Centre NHS Foundation Trust · Hull University Teaching Hospitals NHS Trust · Imperial College Healthcare NHS Trust · Royal Hospital for Neuro-disability · South Warwickshire NHS Foundation Trust · Sheffield Teaching Hospitals NHS Foundation Trust · Oxford University Hospitals NHS Trust · Castel Froma Neuro Care · Inspire Neurocare · The Huntercombe Group · Active Care Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03827187 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)